end,filed,form,Name,Ticker,CIK,Currency,AccountsAndOtherReceivablesNetCurrent,AccountsPayableAndAccruedLiabilitiesCurrent,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccretionExpense,AccrualForTaxesOtherThanIncomeTaxesCurrent,AccruedBonusesCurrent,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AccruedRentCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalOther,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,AdjustmentsToAdditionalPaidInCapitalStockSplit,AdjustmentsToAdditionalPaidInCapitalWarrantIssued,AllocatedShareBasedCompensationExpense,AllowanceForDoubtfulAccountsReceivable,AmortizationOfFinancingCosts,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,AssetImpairmentCharges,Assets,AssetsCurrent,AssetsHeldForSaleNotPartOfDisposalGroupCurrent,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleDebtSecuritiesAmortizedCostBasis,AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax,AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax,AvailableForSaleSecurities,AvailableForSaleSecuritiesAmortizedCost,AvailableForSaleSecuritiesDebtSecurities,BusinessExitCosts1,CapitalExpendituresIncurredButNotYetPaid,CapitalLeaseObligations,CapitalLeaseObligationsCurrent,CapitalLeasesFutureMinimumPaymentsDueCurrent,CapitalLeasesFutureMinimumPaymentsDueInThreeYears,CapitalLeasesFutureMinimumPaymentsDueInTwoYears,CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear,Cash,CashAcquiredFromAcquisition,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashCashEquivalentsAndShortTermInvestments,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashPeriodIncreaseDecrease,CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights,ClassOfWarrantOrRightOutstanding,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ContractWithCustomerLiabilityCurrent,ConversionOfStockSharesIssued1,CostOfRevenue,CostsAndExpenses,CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption,DebtConversionConvertedInstrumentAmount1,DebtConversionConvertedInstrumentSharesIssued1,DebtConversionOriginalDebtAmount1,DebtInstrumentCarryingAmount,DebtInstrumentFaceAmount,DebtInstrumentInterestRateEffectivePercentage,DebtInstrumentPeriodicPayment,DebtInstrumentUnamortizedDiscount,DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction,DeferredFinanceCostsNet,DeferredFinanceCostsNoncurrentGross,DeferredFinanceCostsNoncurrentNet,DeferredIncomeTaxLiabilities,DeferredOfferingCosts,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPropertyPlantAndEquipment,DepreciationDepletionAndAmortization,Dividends,DueToRelatedPartiesCurrent,DueToRelatedPartiesCurrentAndNoncurrent,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,EffectiveIncomeTaxRateReconciliationDeductions,EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCredits,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized,EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions,EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares,ExcessTaxBenefitFromShareBasedCompensationFinancingActivities,FairValueAdjustmentOfWarrants,FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet,FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue,GainContingencyUnrecordedAmount,GainLossOnContractTermination,GainLossOnDispositionOfAssets,GainLossOnDispositionOfAssets1,GainLossOnSaleOfPropertyPlantEquipment,GainLossRelatedToLitigationSettlement,GainsLossesOnExtinguishmentOfDebt,GeneralAndAdministrativeExpense,ImpairmentOfLongLivedAssetsHeldForUse,IncomeTaxExaminationPenaltiesAndInterestExpense,IncomeTaxExpenseBenefit,IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance,IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate,IncomeTaxReconciliationNondeductibleExpenseOther,IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost,IncomeTaxReconciliationStateAndLocalIncomeTaxes,IncomeTaxReconciliationTaxCredits,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInAccountsReceivable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInContractWithCustomerLiability,IncreaseDecreaseInDeferredRevenue,IncreaseDecreaseInDeposits,IncreaseDecreaseInInventories,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncreaseDecreaseInRestrictedCash,InterestAndDebtExpense,InterestExpense,InterestExpenseRelatedParty,InterestPaid,InterestPaidNet,InterestPayableCurrent,InventoryNet,IssuanceOfStockAndWarrantsForServicesOrClaims,LeaseAndRentalExpense,LesseeOperatingLeaseDiscountRate,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LessorOperatingLeasePaymentsToBeReceived,LettersOfCreditOutstandingAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LicenseAndServicesRevenue,LitigationSettlementAmount,LongTermDebt,LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo,LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear,LongTermInvestments,LongTermNotesPayable,MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments,MembersEquity,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NetIncomeLossAvailableToCommonStockholdersDiluted,NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1,NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1,NonoperatingIncomeExpense,NotesPayable,NotesPayableCurrent,NotesPayableFairValueDisclosure,NotesPayableRelatedPartiesClassifiedCurrent,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OperatingLeasesFutureMinimumPaymentsDue,OperatingLeasesFutureMinimumPaymentsDueCurrent,OperatingLeasesFutureMinimumPaymentsDueInFourYears,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OperatingLeasesRentExpenseNet,OperatingLossCarryforwards,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax,OtherExpenses,OtherLiabilitiesCurrent,OtherLiabilitiesNoncurrent,OtherNoncashIncomeExpense,OtherNonoperatingIncomeExpense,PaidInKindInterest,PaymentsForProceedsFromOtherInvestingActivities,PaymentsForRepurchaseOfCommonStock,PaymentsForRestructuring,PaymentsOfCapitalDistribution,PaymentsOfStockIssuanceCosts,PaymentsRelatedToTaxWithholdingForShareBasedCompensation,PaymentsToAcquireAvailableForSaleSecuritiesDebt,PaymentsToAcquireEquipmentOnLease,PaymentsToAcquireMarketableSecurities,PaymentsToAcquirePropertyPlantAndEquipment,PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments,PreferredStockAccretionOfRedemptionDiscount,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfConvertiblePreferredStock,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,ProceedsFromIssuanceOfWarrants,ProceedsFromLegalSettlements,ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities,ProceedsFromNotesPayable,ProceedsFromRelatedPartyDebt,ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans,ProceedsFromRepaymentsOfRestrictedCashFinancingActivities,ProceedsFromSaleAndMaturityOfMarketableSecurities,ProceedsFromSaleOfAvailableForSaleSecuritiesDebt,ProceedsFromSaleOfMachineryAndEquipment,ProceedsFromSaleOfPropertyPlantAndEquipment,ProceedsFromStockOptionsExercised,ProceedsFromWarrantExercises,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ProvisionForDoubtfulAccounts,RealizedInvestmentGainsLosses,ReclassificationsOfTemporaryToPermanentEquity,RelatedPartyTransactionRate,RepaymentsOfDebtAndCapitalLeaseObligations,RepaymentsOfNotesPayable,RepaymentsOfRelatedPartyDebt,ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff,ResearchAndDevelopmentExpense,ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost,ResearchAndDevelopmentInProcess,RestrictedCashAndCashEquivalents,RestrictedCashAndCashEquivalentsAtCarryingValue,RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings,RestrictedStockValueSharesIssuedNetOfTaxWithholdings,RestructuringAndRelatedCostCostIncurredToDate1,RestructuringAndRelatedCostExpectedCost1,RestructuringAndRelatedCostExpectedCostRemaining1,RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated,RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent,RestructuringCharges,RestructuringReserve,RestructuringReserveAccrualAdjustment1,RestructuringReserveCurrent,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerIncludingAssessedTax,RevenueFromGrants,Revenues,RoyaltyExpense,RoyaltyGuaranteesCommitmentsAmount,SaleOfStockConsiderationReceivedPerTransaction,SaleOfStockNumberOfSharesIssuedInTransaction,SalesRevenueNet,SecurityDeposit,SellingAndMarketingExpense,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized,ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity,SharePrice,ShortTermInvestments,StockholdersEquity,StockIssuedDuringPeriodSharesConversionOfUnits,StockIssuedDuringPeriodSharesNewIssues,StockIssuedDuringPeriodValueAcquisitions,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueConversionOfUnits,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueShareBasedCompensation,StockRepurchasedDuringPeriodValue,TemporaryEquityAccretionToRedemptionValueAdjustment,UnbilledReceivablesCurrent,UnrealizedGainLossOnInvestments,UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense,UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued,ValuationAllowanceDeferredTaxAssetChangeInAmount,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition,DebtSecuritiesAvailableForSaleRealizedGain,DebtSecuritiesAvailableForSaleRealizedGainLoss,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost,OperatingLeasePayments,ProceedsFromStockPlans,StockIssuedDuringPeriodValueIssuedForServices
2014-06-30,2014-08-14,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,1081704.0,167738.0,1359405.0,,,,,,,,483342.0,,38307103.0,,,,,,2875000.0,0.0,,100588000.0,,10662994.0,9767954.0,,,,,,,,,,,,,,,,,,7696000.0,,7696325.0,,,,,,,,,,,0.01,50000000.0,3782629.0,3782629.0,37826.0,,,,954000.0,,,,,,,182000.0,0.034,,,,,,,,469000.0,,,,,,,,,,,,,36000.0,,1045000.0,,,-4.73,,,,,,,,,,,,,16748.0,,,,,,,,,,,,,,,,,2937000.0,,,,,,,,,,,,,,,,,,,,,478000.0,476000.0,,,,193140.0,,,,,,,50000.0,,10662994.0,2137301.0,,,,,,,,,,,,,,,,-3289000.0,-3289000.0,,,,,11000.0,10597.0,11000.0,,,4085000.0,-2811000.0,,,,,,,,,,,,,,,60466.0,,,,,,,,,,,,,,,,,,,285000.0,,,,,,,468885.0,,,,,,,,,,,,,,,,,,-3288949.0,1343348.0,860006.0,0.0,,,,,,,,128000.0,,,50000.0,50199.0,,,,,,,,,,,,-29881763.0,,,1621000.0,,,,,1274000.0,35034.0,66000.0,2874740.0,,,,,,,,,,,,,,,,,,,,,,,,8463166.0,,,,,,,,,,,,,,,,,695454.0,,,,,,,,
2014-09-30,2014-11-14,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,939481.0,238516.0,1549998.0,,,,,,119430.0,,517466.0,,39010827.0,,,,,,703000.0,144000.0,,741398.0,,9524766.0,8655558.0,,,,,,,,,,,,,,,,,,,,6388000.0,,,,,,,,,,,0.01,50000000.0,3782629.0,3782629.0,37826.0,,,,900000.0,,,,,,,182000.0,0.034,,,,,,,,,,,,,,,,,,,,,34000.0,,1045000.0,,,-0.4,,,,,,,,,,,,,155563.0,,,,,,,,,,,,,,,,,1760000.0,,,,,,,,,,,,,,,,,,,,,4000.0,,,,,232064.0,,,,,,,50000.0,,,1995078.0,,,,,,,,,,,,,,,,-1637000.0,-1637000.0,,,,,11000.0,10597.0,11000.0,,,2934000.0,-1633000.0,,,,,,,,,,,,,,,116693.0,,,,,,,,,,,,,,,,,,,275000.0,,,,,,,434902.0,,,,,,,,,,,,,,,,,,-1637203.0,1343348.0,825882.0,144000.0,,,,,,,,105000.0,,,50000.0,50236.0,,,,,,,,,,,,-31518965.0,,,1872000.0,,,,,1301000.0,43326.0,169000.0,703725.0,0.0,,,,,,,,54000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4062487.0,,,,,,,,
2014-12-31,2015-03-27,10-K,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,100000.0,,255000.0,1088000.0,,,,183000.0,361000.0,,,555000.0,,12593000.0,300000.0,4298000.0,,,,4298000.0,0.0,,849700.0,,8089000.0,6785000.0,,,,,,,,,,,,164000.0,80000.0,86000.0,,86000.0,,5119000.0,,5119000.0,,,,,4910000.0,,,,,1287899.0,0.01,50000000.0,3782629.0,3782629.0,38000.0,,,,3366000.0,,,27326000.0,,,,,,,,,,47000.0,47000.0,,47000.0,1396000.0,0.0,200000.0,853000.0,,6000.0,74000.0,463000.0,,,1196000.0,200000.0,144000.0,,1045000.0,,,-3.5,,,0.34,,,,,,,,,,74000.0,,0.0,,,,,,,,100000.0,-46000.0,,,,100000.0,,6857000.0,0.0,,0.0,1356000.0,-2682000.0,,1046000.0,-141000.0,4000.0,,383000.0,94000.0,,,,-8000.0,-178000.0,-191000.0,,,1023000.0,,1000.0,,,179000.0,300000.0,,,,,,50000.0,,8089000.0,1989000.0,,,,,,,,,,,,,7397000.0,-274000.0,-2213000.0,-7890000.0,-7890000.0,,164000.0,,,,,,,,11187000.0,-6867000.0,,,,,,,,216000.0,,148000.0,192000.0,,149000.0,,62000.0,,,,80000.0,109000.0,,,1007000.0,,,,,,,,,,266000.0,,,0.01,5000000.0,0.0,0.0,0.0,399000.0,,6644000.0,,,,,,,795000.0,,,,,,,,,,1769000.0,1214000.0,177000.0,,,,42000.0,42000.0,,,347000.0,,,50000.0,50000.0,,,,,,,,,,,,-6640000.0,,,6484000.0,30000.0,30000.0,,,4320000.0,43000.0,717000.0,4298000.0,,,,153306.0,,,,2500.0,154500.0,,152000.0,4.53,,,,,152000.0,4.53,5.43,4.55,,,,5991000.0,,,,,2189000.0,,5844000.0,,,,,,,,,,2255864.0,,,,,,,,
2015-03-31,2015-05-15,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,384000.0,598000.0,,,,,803000.0,,,600000.0,,22348000.0,,708000.0,,,,708000.0,20000.0,,911148.0,,15747000.0,14491000.0,,,,,,,,,,,,148000.0,,65000.0,4000.0,86000.0,,13268000.0,,13268000.0,,,,,8149000.0,,,,,1422679.0,0.01,50000000.0,7504990.0,7504990.0,75000.0,,,,760000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45000.0,,,,,-0.45,,,,,,,,,,,,,483000.0,,0.0,,,,,,,,,,,,,,,1963000.0,,,,,,,,,,,401000.0,-490000.0,,,,,151000.0,-104000.0,,,22000.0,19000.0,,,,330000.0,330000.0,,,,,,,,15747000.0,2495000.0,,,,,,,,,,,,,9302000.0,-44000.0,-1109000.0,-2634000.0,,,,,,,,,1058000.0,,3257000.0,-2612000.0,,,,,,,,,,,,,,,95000.0,,,,94000.0,103000.0,,,20000.0,,,,,,27000.0,,,,44000.0,,,0.01,5000000.0,0.0,0.0,0.0,295000.0,,9346000.0,,,,,,,,,,,,,,,,,1813000.0,1213000.0,24000.0,,,,17000.0,,,,100000.0,,,,,25934.0,-27000.0,,,,,,,,,,-9274000.0,,,1317000.0,,,,,645000.0,43000.0,434000.0,708000.0,,,,135761.0,,,,1000.0,29000.0,,180000.0,4.19,,,,,173879.0,4.19,5.6,2.44,330000.0,,,13149000.0,,3696427.0,,,,,8781000.0,,,,,,,,,,5793082.0,,,,,,,,
2015-06-30,2015-08-14,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,332000.0,581000.0,,,,,477000.0,,,645000.0,,22701000.0,,,,,,712000.0,7000.0,,886401.0,,13094000.0,11859000.0,,,,,,,,,,,,128000.0,,43000.0,7000.0,86000.0,,10448000.0,,10448000.0,,,,,,,,,203214.0,1936740.0,0.01,50000000.0,7845530.0,7845530.0,78000.0,,,,678000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.33,,,,,,,,,,,,,407000.0,,,,,,,,,,,,,,,,,1778000.0,,,,,,,,,,,,,,,,,,,,,72000.0,,,,28000.0,536000.0,,,,,,,,,13094000.0,2075000.0,,,,,,,,,,,,,,,,-2562000.0,,,,,,,,,1105000.0,,3224000.0,-2490000.0,,,,,,,,,,,,,,,42000.0,,,,98000.0,76000.0,,,,,,,,,,,,,,,,0.01,5000000.0,0.0,0.0,,294000.0,,,,,,,,,,,,,,,,,,,1837000.0,1192000.0,4000.0,,,,,,,,194000.0,,,,,,,,,,,,,,,,-11836000.0,,,1457000.0,,,,,734000.0,43000.0,574000.0,,,,,1157240.0,,,,,,2000.0,179000.0,4.17,,,,2000.0,179000.0,4.17,,,,,,10943000.0,,,,,,,,,,,,,,,,,7785670.0,,,,,,,,
2015-09-30,2015-11-13,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,195000.0,547000.0,,,,,713000.0,,,692000.0,,27515000.0,,,,,,838000.0,0.0,,982766.0,,14797000.0,13605000.0,,,,,,,,,,,,108000.0,,22000.0,7000.0,86000.0,,,,12124000.0,,,,,,,,,203214.0,1881799.0,0.01,50000000.0,10635454.0,10635454.0,106000.0,,,,577000.0,3629000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-0.39,,,,,,,,,,,,,593000.0,,,,,,,,,,,,,,,,,2003000.0,,,,,,,,,,,,,,,,,,,,,24000.0,,,,50000.0,364000.0,,,,,,,,,14797000.0,2114000.0,,,,,,,,,,,,,,,,-3152000.0,,,,,,,,,1105000.0,,3629000.0,-3128000.0,,,,,,,,,,,,,,,70000.0,,,,101000.0,50000.0,,,,,,,,,,,,,,,,0.01,5000000.0,0.0,0.0,0.0,570000.0,,,,,,,,,,,,,,,,,,,1869000.0,1177000.0,4000.0,,,,,,,,253000.0,,,,,,,,,,,,,,,,-14988000.0,,,1335000.0,,,,,501000.0,15000.0,796000.0,,,,,673027.0,45795.0,3.88,,,,,653800.0,2.27,,,,,653800.0,2.27,,,,,,12633000.0,,,,,,,,,,,,,,,,,8125133.0,,,,,,,,
2015-12-31,2016-03-21,10-K,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,242000.0,394000.0,,,,592000.0,1018000.0,,,739000.0,,28371000.0,,3015000.0,,,,3015000.0,0.0,,12768000.0,,12902000.0,11734000.0,,,,,,,,,,,,88000.0,,86000.0,,7000.0,,,,21235000.0,,,,,5713000.0,,,,203214.0,1881799.0,0.01,50000000.0,709024.0,709024.0,7000.0,,,,2472000.0,13725000.0,,,,,,,,,,,,,,,,5046000.0,0.0,350000.0,3913000.0,,52000.0,257000.0,810000.0,,14000.0,4696000.0,350000.0,184000.0,,,,,-21.02,,,0.34,,,,,,,,,,234000.0,,,,,,,,,169000.0,,,,,,,,7692000.0,0.0,0.0,0.0,3625000.0,-3851000.0,19000.0,526000.0,-277000.0,23000.0,,633000.0,-694000.0,,,,28000.0,8000.0,-28000.0,,,141000.0,,6000.0,,,187000.0,330000.0,,,,,,,,12902000.0,2468000.0,,,,,,,,,,,,,12706000.0,-95000.0,-6898000.0,-11328000.0,,,,,,,,,1105000.0,,13725000.0,-11187000.0,,,,,,,,173000.0,,,148000.0,,234000.0,,84000.0,,,141000.0,103000.0,24000.0,,,132000.0,,,,,,363000.0,,,,123000.0,,,0.01,5000000.0,0.0,0.0,0.0,321000.0,,13095000.0,,,,,,,,,50000.0,,,,,,,,1892000.0,1153000.0,33000.0,,,,76000.0,,,,1002000.0,,,,,,-363000.0,,,,,,,,,,-17968000.0,,,5706000.0,30000.0,30000.0,,,2538000.0,15000.0,2559000.0,3015000.0,,,,695260.0,78009.0,3.2,,33833.0,513400.0,,42104.0,34.2,,,,,631567.0,2.28,2.14,1.6,,,,-45290000.0,,,,,,,12765000.0,,,,,,,,,,539460.0,,,,,,,,
2016-03-31,2016-05-16,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,102000.0,490000.0,,42000.0,,609000.0,1149000.0,,,786000.0,,28958000.0,,713000.0,,,,38000.0,0.0,,1082314.0,,10796000.0,9672000.0,,,,,,,,,,,,67000.0,,,,7000.0,65000.0,,0.0,16960000.0,,,,,-4275000.0,,,,203214.0,2233591.0,0.01,50000000.0,10709080.0,10709080.0,107000.0,,,,629000.0,,,,,,,,,,,0.0,,,,,,,,,,,,,,,,,,81000.0,,,,,-5.58,,,,,,,,,,,,,253000.0,,,,,,,,,,,,,,,,,992000.0,,,,,,,,,,235000.0,-36000.0,-60000.0,-771000.0,,-173000.0,,82000.0,63000.0,,89000.0,23000.0,,41000.0,,,269000.0,,100000.0,,,,,,,10796000.0,2443000.0,917000.0,,,,,,,,,,,,0.0,-105000.0,-4170000.0,-3623000.0,-3635000.0,,,0.0,7000.0,,,,1105000.0,,4458000.0,-3541000.0,,,,,,,,,,,,,,,39000.0,,,,87000.0,14000.0,,-82000.0,22000.0,,,,,0.0,26000.0,,,,105000.0,,,0.01,5000000.0,0.0,0.0,,353000.0,,0.0,,,,,,,,,,,,,,0.0,,,1895000.0,1109000.0,2000.0,,0.0,,21000.0,0.0,,,3466000.0,,,,,73626.0,-26000.0,,,,,,,,,,-20726000.0,,0.0,2050000.0,,,,,917000.0,15000.0,510000.0,42000.0,,,,632891.0,132378.0,2.66,,65407.0,14800.0,,580960.0,2.18,,,,,580960.0,2.18,2.76,0.53,,,,8339000.0,,,,,,,,,,-12000.0,,,,,,,651041.0,,,,,,,,
2016-06-30,2016-08-15,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,94000.0,658000.0,,,,634000.0,1331000.0,,,834000.0,,29562000.0,,,,,,42000.0,0.0,,1578856.0,,9042000.0,7966000.0,,,,,,,,,,,,46000.0,,,,7000.0,43000.0,,,8377000.0,,,,,,,,,203214.0,2147624.0,0.01,50000000.0,10777906.0,10777906.0,108000.0,,,,628000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,100000.0,,,,,-5.88,,,,,,,,,,,,,303000.0,,,,,,,,,,,,,,,,,1210000.0,0.0,0.0,,,,,,,,,,,,,,,,,,83000.0,23000.0,,,,,213000.0,,100000.0,,,,,,,9042000.0,2597000.0,847000.0,,,,,,,,,,,,,,,-3524000.0,-3536000.0,,,,9000.0,,,,1105000.0,,4565000.0,-3450000.0,,,,,,,,,,,,,,,83000.0,,,,67000.0,8000.0,,-74000.0,,,,,,,,,,,,,,0.01,5000000.0,0.0,0.0,,594000.0,,,,,,,,,,,,,,,,,,,1895000.0,1061000.0,0.0,,,,,,,,3355000.0,,,,,,,,,,,,,,,,-23233000.0,,268000.0,2109000.0,,,,,1115000.0,15000.0,555000.0,,,,,637708.0,148798.0,2.22,,,,,622837.0,1.94,,,,,622837.0,1.94,,,,,,6437000.0,,,,,,,,,,12000.0,,,,,,,601667.0,,,,,,,,
2016-09-30,2016-10-26,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,51000.0,733000.0,,,,722000.0,1649000.0,,,881000.0,,29650000.0,,,,,,45000.0,10000.0,,1481819.0,,7541000.0,6512000.0,,,,,,,,,,,,25000.0,,,,7000.0,22000.0,,,24598000.0,,,,,,,,,203214.0,2132268.0,0.01,50000000.0,10790422.0,10790422.0,108000.0,,,,599000.0,2705000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,100000.0,,,,,-6.92,,,,,,,,,,,,,250000.0,,,,,,,,,,,,,,,,,2053000.0,0.0,0.0,,,,,,,,,,,,,,,,,,78000.0,23000.0,,,,,62000.0,,100000.0,,,,,,,7541000.0,2853000.0,715000.0,,,,,,,,,,,,,,,-4153000.0,-4166000.0,,,,7000.0,,,,1105000.0,,5018000.0,-4082000.0,,,,,,,,,,,,,,,228000.0,,,,48000.0,2000.0,,-71000.0,,,,,,,,,,,,,,0.01,5000000.0,0.0,0.0,,366000.0,,,,,,,,,,,,,,,,,,,1895000.0,1014000.0,7000.0,,,,,,,,2965000.0,,,,,,,,,,,,,,,,-25072000.0,,221000.0,,,,,,936000.0,15000.0,373000.0,,,,,709248.0,262194.0,2.08,,,,,580941.0,1.93,,,,,580941.0,1.93,,,,,,4686000.0,,,,,,,,,,13000.0,,,,,,,601667.0,,,,,,,,
2016-12-31,2017-03-24,10-K,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,1007000.0,20000.0,,158000.0,38000.0,860000.0,3909000.0,124000.0,221000.0,2558000.0,,5147000.0,,198000.0,,,0.0,198000.0,54000.0,,15421000.0,797000.0,24760000.0,23877000.0,170000.0,,,,,,,,,2037000.0,,4000.0,,,,,,,0.0,22104000.0,,,,,869000.0,,80.7,,13534.0,118694.0,0.01,100000000.0,833744.0,833744.0,8000.0,,,,2548000.0,15845000.0,,,,,4667000.0,,,,14000.0,,31000.0,,,,,26342000.0,,0.0,20961000.0,52000.0,2785000.0,505000.0,0.0,1182000.0,49000.0,26342000.0,10000.0,341000.0,,,,,-37.41,,0.0,0.35,-0.43,0.0,0.001,0.0,,-0.004,0.001,0.032,0.052,928000.0,,,,,3000.0,3000.0,39000.0,,133000.0,,,,,,,-71000.0,9289000.0,0.0,0.0,,3086000.0,-4309000.0,364000.0,721000.0,-193000.0,,292000.0,2028000.0,20000.0,2211000.0,,-519000.0,,-123000.0,426000.0,,326000.0,95000.0,,164000.0,,,64000.0,281000.0,300000.0,,,,,,9705000.0,24760000.0,6885000.0,2814000.0,,,,,,,,,2820000.0,,,15874000.0,-250000.0,-14755000.0,-23248000.0,-23309000.0,,,0.0,39000.0,4789000.0,1969000.0,,1045000.0,,20464000.0,-16987000.0,,,,,,,,,,,,,240000.0,,60000.0,258000.0,,166000.0,4000.0,0.0,,-60000.0,93000.0,,2000.0,292000.0,,,171000.0,,,1000000.0,250000.0,,49000.0,0.01,5000000.0,0.0,0.0,,1753000.0,,,,16091000.0,,,,0.0,,0.0,,1000000.0,,,,213000.0,,,3183000.0,625000.0,74000.0,,0.0,,84000.0,333000.0,,,17598000.0,,,,,,-171000.0,,,,,,,1745000.0,,1745000.0,-67076000.0,,663000.0,,86000.0,30000.0,,,3986000.0,,1669000.0,198000.0,,,4182404.0,67695.0,37465.0,28.83,800000.0,10425.0,5786.0,,37465.0,28.83,,,,,37465.0,28.83,38.83,7.71,,,,-61921000.0,,,,,,,281000.0,213000.0,2000.0,49000.0,,,,,7400000.0,,614017.0,,,,,,,,
2017-03-31,2017-05-11,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,1125000.0,277000.0,,32000.0,37000.0,,4180000.0,496000.0,50000.0,2627000.0,,121841000.0,,419000.0,,,,419000.0,,,2978000.0,,57794000.0,56939000.0,,,,,,,,,,,,,,,,,,,1280000.0,46335000.0,,,,,32169000.0,,,,,,0.01,100000000.0,21401828.0,21401828.0,214000.0,,,,,,,,,,4167000.0,,,,11000.0,224000.0,25000.0,,,,,,,,,,,,,,,,,73000.0,,,,,-0.6,,,,,,,,,,,,,749000.0,7000000.0,,,,,,,51000.0,82000.0,,,,,,,,3281000.0,0.0,0.0,,,,,,,,118000.0,,257000.0,-1054000.0,,0.0,,,534000.0,,71000.0,,,38000.0,,,,,100000.0,,,,,,9800000.0,57794000.0,7279000.0,10000.0,,4167000.0,,,667000.0,2000000.0,1500000.0,,2347000.0,,,39116000.0,1236000.0,-8183000.0,-6980000.0,-6985000.0,,,1076000.0,30000.0,4321000.0,1974000.0,,,1.0,7401000.0,-6939000.0,,,,,,,1357000.0,,277000.0,404000.0,391000.0,285000.0,,,77000.0,258000.0,,,,174000.0,,-41000.0,,,,,,1176000.0,,,,,44000.0,,5000.0,0.01,5000000.0,,,,2389000.0,,40703000.0,,,,,,,,0.0,,,,,,89000.0,,,3224000.0,597000.0,,,76981000.0,,,500000.0,,,4120000.0,,,,,,,,,,,,,,,,-74061000.0,462000.0,452000.0,,,,,,462000.0,,,419000.0,,,,,,,,,,,,,,,,,,,,,,,,47994000.0,,,204000.0,,,,39156000.0,89000.0,,5000.0,,,,,,,11555286.0,,,,,,,,
2017-06-30,2017-08-11,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,632000.0,539000.0,,,15000.0,,4019000.0,277000.0,67000.0,2697000.0,,122494000.0,,,,,,595000.0,,,,,50026000.0,49350000.0,,,,,,,,,,,,,,,,,,,,46335000.0,,,,,,,,,,830428.0,0.01,100000000.0,21483540.0,21483540.0,215000.0,-7312000.0,,,,,,,,,3667000.0,,,,8000.0,,19000.0,,,,,,,,,,,,,,,,,100000.0,,,,,-0.34,,,,,,,,,,,,,883000.0,7600000.0,,200000.0,,,,,,82000.0,,,,,,,,2581000.0,0.0,0.0,,,,,,,,,,,,,,,,,,64000.0,,,,,,,,100000.0,,,,,,8690000.0,50026000.0,6630000.0,488000.0,,3667000.0,,,667000.0,2000000.0,1000000.0,,1871000.0,,,,,,-7312000.0,-7312000.0,,,,102000.0,3850000.0,1979000.0,,,,8068000.0,-7350000.0,,,,,,,1261000.0,,277000.0,404000.0,391000.0,189000.0,,,81000.0,50000.0,0.0,,,189000.0,,38000.0,,,,,,,,,,,,,,0.01,5000000.0,,,,2476000.0,,,,,,,,,,,,,,,,,,,3323000.0,626000.0,,,,,,,,,5487000.0,,,,,,,,,,,,,,,,-81373000.0,718000.0,230000.0,,,,,,718000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,41336000.0,,,,,,,,,,0.0,,,,,,,21409708.0,,,,,,,,
2017-09-30,2017-11-09,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,409000.0,635000.0,,,,,4142000.0,457000.0,70000.0,2776000.0,,125973000.0,,,,,,679000.0,,,,,47081000.0,46421000.0,,,,,,,,,,,,,,,,,,,,42805000.0,,,,,,,,,,773067.0,0.01,100000000.0,21886568.0,21886568.0,219000.0,-5834000.0,,,,,,,,,3167000.0,,,,6000.0,,14000.0,,,,100000.0,,,,,,,,,,,,,100000.0,,,,,-0.27,,,,,,,,,,,,,1061000.0,7400000.0,,,,,,,,82000.0,,,,,,,,2502000.0,0.0,0.0,,,,,,,,,,,,,,,,,,58000.0,,,,,,,,100000.0,,,,,,8096000.0,47081000.0,6534000.0,1493000.0,,3167000.0,,,667000.0,2000000.0,500000.0,,1391000.0,,,,,,-5834000.0,-5834000.0,,,,113000.0,3374000.0,1983000.0,,,,7520000.0,-5889000.0,,,,,,,1167000.0,,277000.0,404000.0,391000.0,95000.0,,,74000.0,50000.0,0.0,,,171000.0,,55000.0,,,,,,,,,,,,,,0.01,5000000.0,,,,2981000.0,,,,,,,,,,,,,,,,,,,3386000.0,610000.0,,,,,,,,,5018000.0,,,,,,,,,,,,,,,,-87207000.0,1631000.0,138000.0,,,,,,1631000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,38985000.0,,,,,,,,,,0.0,,,,,,,21572498.0,,,,,,,,
2017-12-31,2018-03-15,10-K,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,906000.0,1456000.0,0.0,94000.0,,,2991000.0,232000.0,74000.0,2835000.0,0.0,131877000.0,,2409000.0,400000.0,,127000.0,2409000.0,,,2912000.0,,52481000.0,51868000.0,,,,,,,,,,,,,,,,,,,1280000.0,47441000.0,25337000.0,,47441000.0,,25337000.0,,,,,742058.0,0.01,100000000.0,22568006.0,22568006.0,226000.0,-26512000.0,,,,,,,,,10000000.0,,,,119000.0,,0.0,,,,200000.0,22509000.0,,0.0,18257000.0,,2287000.0,,439000.0,697000.0,,22509000.0,,308000.0,,,,,-1.67,,0.0,0.35,0.145,-0.407,0.0,0.029,,0.019,0.006,0.031,0.048,1538000.0,7000000.0,,,,0.0,,,-51000.0,82000.0,,,,,,,,13460000.0,0.0,0.0,,,,,,,,-101000.0,,1436000.0,-2205000.0,,0.0,,,724000.0,,383000.0,,,446000.0,446000.0,,,0.0,300000.0,,,,,,13971000.0,52481000.0,3897000.0,3097000.0,,10000000.0,0.0,3667000.0,4000000.0,2333000.0,,,9922000.0,,,52470000.0,1034000.0,-28167000.0,-32898000.0,-32903000.0,,,1076000.0,403000.0,9922000.0,0.0,,,1.0,30535000.0,-26532000.0,,,,,,,1072000.0,391000.0,,277000.0,404000.0,,,73200000.0,102000.0,50000.0,0.0,,,152000.0,,-32000.0,,,,,,,,,,0.0,246000.0,,5000.0,0.01,5000000.0,,,,2971000.0,,,,0.0,,,,10000000.0,,110000.0,,0.0,,,0.0,307000.0,,,3398000.0,563000.0,,,76981000.0,,,4667000.0,,,24621000.0,,,,,,,,,,,,,,,,-93593000.0,5195000.0,906000.0,,,,,,5195000.0,,,2409000.0,,902720.0,4182404.0,,,,3800000.0,,,,,,,,,,,,,,,,0.0,38510000.0,,,204000.0,,,110000.0,,307000.0,,5000.0,,,,,-3800000.0,,19244605.0,,,,,,,,
2018-03-31,2018-05-09,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,760000.0,4809000.0,0.0,96000.0,,,3377000.0,236000.0,77000.0,2878000.0,,170658000.0,,790000.0,,,,790000.0,,,2912000.0,,86992000.0,86353000.0,,,,,,,,,,,,,,,,,,,0.0,78099000.0,30658000.0,,,,30658000.0,,,,,867171.0,0.01,100000000.0,30186540.0,30186540.0,302000.0,-4661000.0,,,,,,,,,10000000.0,,,,104000.0,0.0,,,,,,,,,,,,,,,,,,69000.0,,,,,-0.18,,,,,,,,,,,,,607000.0,10400000.0,,,,,,,,,,,,,,,,2990000.0,0.0,0.0,,,,,,,,-146000.0,,3353000.0,365000.0,,,,,521000.0,,209000.0,,,112000.0,112000.0,,,,100000.0,,,,,,14286000.0,86992000.0,4137000.0,4756000.0,,10000000.0,0.0,3667000.0,4000000.0,2333000.0,,,10018000.0,,,38114000.0,-95000.0,-7361000.0,-4661000.0,-4661000.0,,,0.0,167000.0,10018000.0,,,,1.0,9403000.0,-4619000.0,,,,,,,975000.0,294000.0,,277000.0,404000.0,,,,110000.0,50000.0,0.0,,,131000.0,,-42000.0,,,,,,,,,,0.0,95000.0,,,0.01,5000000.0,,,,3445000.0,,,,,,,,,,110000.0,,0.0,,,,112000.0,,,3467000.0,589000.0,,,0.0,,,0.0,,,6413000.0,,,,,,,,,,,,,,,,-98254000.0,4784000.0,28000.0,,,,,,4784000.0,,,790000.0,,902720.0,4182404.0,,,,,,,,,,,,,,,,,,,,,72706000.0,,,,,,110000.0,37845000.0,112000.0,,0.0,,,,,,,26483112.0,,,,,,,,
2018-06-30,2018-08-08,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,461000.0,1198000.0,,,,,3534000.0,78000.0,80000.0,2947000.0,4000.0,174329000.0,,984000.0,,,,,,,,,81887000.0,81223000.0,,,,,4000.0,,32900000.0,32900000.0,,,,,,,,,,,,43402000.0,,,,,,,,,,759359.0,0.01,100000000.0,30595793.0,30595793.0,306000.0,-8710000.0,,,,,,,,,10000000.0,,,,92000.0,,,,,,,,,,,,,,,,,,,100000.0,,,,,-0.29,,,,,,,,,,,,,1021000.0,10100000.0,,,,,,,,,,,,,,,,2668000.0,0.0,0.0,,,,,,,,,,,,,,,,,,214000.0,,,,,,,,100000.0,,,,,,14216000.0,81887000.0,4284000.0,,,10000000.0,0.0,3667000.0,4000000.0,2333000.0,,,9822000.0,,,,,,-8714000.0,-8710000.0,,,,361000.0,10111000.0,289000.0,,,,11043000.0,-8861000.0,,,,,,,877000.0,196000.0,,277000.0,404000.0,,,,156000.0,50000.0,4000.0,,,110000.0,,147000.0,,,,,,,,,,,,,,0.01,5000000.0,,,,3763000.0,,,,,,,,,,,,,,,,,,,3561000.0,614000.0,,0.0,,,,,,,8375000.0,,,,,,,,,,,,,,,,-106968000.0,2182000.0,,,,,,,,,,,,,4182404.0,,,,,,,,,,,,,,,,,,,,32860000.0,67671000.0,,,,,,,,34000.0,,0.0,,,,,,,30295200.0,,,,,,,,
2018-09-30,2018-11-07,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,1206000.0,1382000.0,,,,,4336000.0,101000.0,83000.0,3015000.0,-6000.0,176395000.0,,968000.0,,,,,,,,,76553000.0,75752000.0,,,,,,6000.0,38800000.0,38800000.0,,,,,,,,,,,,31700000.0,,,,,,,,,,722269.0,0.01,100000000.0,30833367.0,30833367.0,308000.0,-9021000.0,,,,,,,,,10000000.0,,,,80000.0,,,,,,,,,,,,,,,,,,,100000.0,,,,,-0.29,,,,,,,,,,,,,1259000.0,9300000.0,,,,,,,,,,,,,,,,2696000.0,0.0,0.0,,,,,,,,,,,,,,,,,,222000.0,,,,,,,,100000.0,,,,,,15835000.0,76553000.0,6833000.0,,,10000000.0,0.0,3667000.0,4000000.0,2333000.0,,,8914000.0,,,,,,-9011000.0,-9021000.0,,,,362000.0,10205000.0,1291000.0,,,,10095000.0,-9151000.0,,,,,,,780000.0,99000.0,,277000.0,404000.0,,,,164000.0,50000.0,-10000.0,,,88000.0,,140000.0,,,,,,,,,,,,,,0.01,5000000.0,,,,3843000.0,,,,,,,,,,,,,,,,,,,3766000.0,751000.0,,0.0,,,,,,,7399000.0,,,,,,,,,,,,0.0,,,,-115979000.0,944000.0,,,,,,,,,,,,,4182404.0,,,,,,,,,,,,,,,,,,,,38827000.0,60718000.0,,,,,,132000.0,,33000.0,,0.0,,,,,,,30723704.0,,,,,,,,
2018-12-31,2019-03-14,10-K,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,571000.0,24000.0,416000.0,376000.0,,,3868000.0,246000.0,124000.0,3090000.0,-3000.0,177335000.0,,3679000.0,,,0.0,3679000.0,,,3576000.0,,66147000.0,65370000.0,,,3000.0,29900000.0,,3000.0,29900000.0,29900000.0,29900000.0,,,,,,,,,,0.0,32606000.0,-14835000.0,,32606000.0,-14835000.0,,,,,,705317.0,0.01,100000000.0,30839463.0,30839463.0,308000.0,-32706000.0,,,,,,,,,10000000.0,,,,69000.0,,,,,,,33136000.0,,0.0,24137000.0,,6571000.0,,876000.0,854000.0,,33136000.0,,281000.0,,,,,-1.4300000000000002,,0.0,0.21,-0.325,-0.007,,0.0,,-0.01,-0.001,0.03,-0.103,1704000.0,8300000.0,,,,,,,,,,,,,,,,13744000.0,0.0,0.0,,,,,,,,-335000.0,,-1432000.0,791000.0,,,,,-51000.0,,873000.0,,,,489000.0,,,,300000.0,,,,,,14803000.0,66147000.0,6733000.0,,,10000000.0,2333000.0,,3667000.0,4000000.0,,,8004000.0,,,41916000.0,-29907000.0,-26844000.0,-43020000.0,-43017000.0,,,0.0,1254000.0,10298000.0,2294000.0,,,1.0,41470000.0,-33084000.0,,,,,,,681000.0,404000.0,,,277000.0,,,97900000.0,174000.0,50000.0,-3000.0,,,66000.0,,136000.0,,,,,,3037000.0,,,,62462000.0,445000.0,,,0.01,5000000.0,,,,2865000.0,,44529000.0,,,,,,0.0,,242000.0,,33000000.0,,,0.0,182000.0,,,3817000.0,727000.0,,0.0,0.0,,,0.0,,,38655000.0,,,,,,,,,,,,,0.0,,,-126296000.0,8862000.0,,,,,,,,,,3679000.0,,,4182404.0,,,,1600000.0,,,2698000.0,,,2421000.0,1979000.0,4.2,2698000.0,3527000.0,5.76,,,,,29875000.0,51344000.0,,,,,,242000.0,,182000.0,,0.0,,-3000.0,,,10600000.0,,29600332.0,,,,,,,,
2019-03-31,2019-05-09,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,517000.0,6000.0,182000.0,94000.0,,,3044000.0,270000.0,90000.0,3159000.0,2000.0,178570000.0,,1018000.0,,,,1018000.0,,,4493000.0,,54950000.0,54209000.0,,2000.0,,32800000.0,,,,,32800000.0,,,,,,,,,,,18195000.0,-14411000.0,51000000.0,18195000.0,-14411000.0,,,,,,1022705.0,0.01,100000000.0,30921219.0,30921219.0,309000.0,-11624000.0,,,,,,,,,10000000.0,,,,57000.0,,,,,,,,,,,,,,,,,,,73000.0,,,,,-0.38,,,,,,,,,,,,,786000.0,9600000.0,,,,,,,,,,,,0.0,,,,3357000.0,0.0,0.0,,,,,,,,-54000.0,,-18000.0,-849000.0,,,,,298000.0,,232000.0,,,,136000.0,,,,100000.0,,,,,,13994000.0,54950000.0,6860000.0,,,10000000.0,,,3667000.0,4000000.0,2333000.0,,7093000.0,,,218000.0,-2820000.0,-11809000.0,-11629000.0,-11629000.0,,,,339000.0,10392000.0,3299000.0,,,1.0,12108000.0,-11736000.0,100000.0,,,,,,580000.0,303000.0,,,277000.0,,,,113000.0,50000.0,5000.0,,,41000.0,,107000.0,,,,,,4000.0,,,,23783000.0,37000.0,,,0.01,5000000.0,,,,3164000.0,,138000.0,,,,,,,,84000.0,,21000000.0,,,0.0,0.0,,,3850000.0,691000.0,,0.0,,,,0.0,,,8751000.0,,,,,,,,,,,,,,,,-137925000.0,372000.0,,,,,,,,,,1018000.0,,,4182404.0,,,,,,,,,,,,,,,,,,,,32844000.0,40956000.0,,,,,,84000.0,134000.0,,,,,5000.0,,,,,30886085.0,,,,,,,,
2019-06-30,2019-08-08,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,1232000.0,325000.0,,,,,3946000.0,218000.0,93000.0,3220000.0,11000.0,179937000.0,,1075000.0,,,,,,,,,48782000.0,48080000.0,,11000.0,,19900000.0,,,,,19900000.0,,,,,,,,,,,24007000.0,,43900000.0,24007000.0,,,,,,,953216.0,0.01,100000000.0,31037363.0,31037363.0,310000.0,-8887000.0,,,,,,,,,9667000.0,,,,46000.0,,,,,,,,,,,,,,,,,,,100000.0,,,,,-0.29,,,,,,,,,,,,,1206000.0,8600000.0,,,,,,,,,,,,,,,,2857000.0,0.0,0.0,,,,,,,,,,,,,,,,,,229000.0,,,,,,,,100000.0,,,,,,15345000.0,48782000.0,9148000.0,,,9667000.0,,,3667000.0,4000000.0,2000000.0,,6181000.0,,,,,,-8896000.0,-8896000.0,,,,275000.0,10151000.0,3970000.0,,,,11456000.0,-8942000.0,100000.0,,,,,,479000.0,202000.0,,,277000.0,,,,139000.0,50000.0,9000.0,,,0.0,,46000.0,,,,,,,,,,,,,,0.01,5000000.0,,,,3808000.0,,,,,,,,,,,,,,,,,,,3872000.0,652000.0,,0.0,,,,,,,8599000.0,,,,,,,,,,,,0.0,,,,-146821000.0,2514000.0,,,,,,,,,,,,,4182404.0,,,,,,,,,,,,,,,,,,,,19940000.0,33437000.0,,,,,,,278000.0,15000.0,,,,9000.0,,,,,30983918.0,,,,,,,,
2019-09-30,2019-11-08,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,1556000.0,979000.0,,,,,4857000.0,263000.0,88000.0,3291000.0,3000.0,180905000.0,,874000.0,,,,,,,,,38813000.0,38217000.0,,3000.0,,9000000.0,,,,,9000000.0,,,,,,,,,,,24857000.0,,33800000.0,24857000.0,,,,,,,1290930.0,0.01,100000000.0,31181749.0,31181749.0,312000.0,-11238000.0,,,,,,,,,8667000.0,,,,39000.0,,,,,,,,,,,,,,,,,,,100000.0,,,,,-0.36,,,,,,,,,,,,,652000.0,6400000.0,,,,,,,,,,,,,,,,2898000.0,0.0,0.0,,,,,,,,,,,,,,,,,,204000.0,,,,,,,,100000.0,,,,,,15644000.0,38813000.0,10385000.0,,,8667000.0,,,3667000.0,4000000.0,1000000.0,,5259000.0,,,,,,-11230000.0,-11230000.0,,,,204000.0,9231000.0,3972000.0,,,,11925000.0,-11230000.0,100000.0,,,,,,379000.0,102000.0,,,277000.0,,,,103000.0,0.0,-8000.0,,,0.0,,0.0,,,,,,,,,,,,,,0.01,5000000.0,,,,3400000.0,,,,,,,,,,,,,,,,,,,3887000.0,596000.0,,0.0,,,,,,,9027000.0,,,,,,,,1500000.0,400000.0,,,0.0,804000.0,,,-158051000.0,695000.0,,,,,,,,,,,,,4182404.0,,,,,,,,,,,,,,,,,,,,8981000.0,23169000.0,,,,,,26000.0,,70000.0,,,,-8000.0,,,,,31081594.0,,,,,,,,
2019-12-31,2020-03-13,10-K,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,1096000.0,108000.0,432000.0,340000.0,,,5108000.0,254000.0,66000.0,3348000.0,0.0,183900000.0,,3970000.0,,,,3970000.0,,0.0,236000.0,,30262000.0,29739000.0,,0.0,0.0,2000000.0,,,,,2000000.0,,,,,,,,,,0.0,,,26800000.0,24846000.0,-7760000.0,,,268.95,46522.0,3101.0,1826218.0,0.01,100000000.0,2324126.0,2324126.0,23000.0,-41870000.0,0.0,,,,,,,,7667000.0,,,,32000.0,,,,,0.0,,46240000.0,0.0,0.0,32792000.0,,10812000.0,,1202000.0,829000.0,,46240000.0,,288000.0,,,,,-20.349999999999998,,0.0,0.21,-0.313,0.0,,,0.0,-0.039,0.004,0.037,-0.101,508000.0,4400000.0,,,0.0,,,,,,,,,,,,,14180000.0,0.0,0.0,,,,,,,,525000.0,,84000.0,1084000.0,,,,,-126000.0,,835000.0,,,,511000.0,,,0.0,,,,300000.0,,,14508000.0,30262000.0,10180000.0,,,7667000.0,4000000.0,,,3667000.0,,0.0,4328000.0,,,70000.0,28226000.0,-36056000.0,-51991000.0,-51994000.0,,,,941000.0,8304000.0,3976000.0,,,1.0,46440000.0,-41979000.0,300000.0,0.0,,,0.0,,,,,,,,,133000000.0,122000.0,0.0,3000.0,,,0.0,0.0,-47000.0,,0.0,,519000.0,,77000.0,,,,32690000.0,84000.0,,,0.01,5000000.0,0.0,0.0,0.0,2894000.0,,2283000.0,0.0,,2480000.0,,,0.0,,110000.0,,61000000.0,,,,87000.0,,,3871000.0,523000.0,,0.0,,,,2333000.0,,0.0,43211000.0,34794000.0,0.0,,,,,,,,44.0,0.5,2900000.0,1515000.0,,,-168169000.0,5341000.0,,,,,,2557544.0,,,,3970000.0,,,,,,,100000.0,,,,,,,,,,,,,,,,1999000.0,15754000.0,,,,,,110000.0,,87000.0,,,,3000.0,,0.0,13100000.0,,2089094.0,,,,,,,,
2020-03-31,2020-05-08,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,1629000.0,4000.0,1000.0,63000.0,,,3055000.0,282000.0,0.0,3374000.0,,202685000.0,,664000.0,,,,664000.0,,,822720.0,,39050000.0,38341000.0,,,,,,,,,,,,,,,,,,,,,,36100000.0,36103000.0,11257000.0,,,1.13,7535815.0,7535815.0,1895040.0,0.01,100000000.0,53077348.0,53077348.0,531000.0,-8044000.0,,,,,,,,,6667000.0,,,,27000.0,,,,,,,,,,,,,,,,,,,68000.0,,,,,-2.65,,,,,,,,,,,,,524000.0,4600000.0,,,,,,,,,,,,-11000.0,,,,2723000.0,0.0,0.0,,,,,,,,410000.0,,-104000.0,-2245000.0,,,,,-540000.0,,141000.0,,,,61000.0,,,,,0.06,700000.0,300000.0,,,12050000.0,39050000.0,8661000.0,,,,,,,,,,3389000.0,,,17715000.0,2001000.0,-8459000.0,-8044000.0,-8044000.0,,,,95000.0,7366000.0,3977000.0,,,1.0,8826000.0,-7998000.0,100000.0,306000.0,,,266000.0,100000.0,,,,,,,,,81000.0,,0.0,,,,-86000.0,,,,,1218000.0,,1068000.0,,,,0.0,0.0,,,,5000000.0,,0.0,,2234000.0,,19754000.0,,,19783000.0,,,,,16000.0,,2000000.0,,,1000.0,13000.0,,,3817000.0,443000.0,,0.0,,,,1000000.0,,,6103000.0,6103000.0,,,,,,2200000.0,,,44.0,0.5,119000.0,416000.0,,,-176216000.0,828000.0,,,,,,2557544.0,,,,664000.0,,,,,,,,,,,,,,,,,,,,,,,0.0,27000000.0,,,,,,16000.0,,13000.0,,,,0.0,,,,,3031756.0,,,,,,,,
2020-06-30,2020-08-05,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,286000.0,248000.0,,,,,3020000.0,105000.0,0.0,3435000.0,,203291000.0,,623000.0,,,,623000.0,,,,,33485000.0,32521000.0,,,,,,,,,,,,,,,,,,,,,,30600000.0,30582000.0,,,,1.13,7535815.0,7535815.0,1541083.0,0.01,100000000.0,53077348.0,53077348.0,531000.0,-6435000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,64000.0,,,,-1.82,-0.12,-1.82,,,,,,,,,,,,686000.0,3900000.0,,,,,,,,,,,,,,,,2706000.0,0.0,0.0,,,,,,,,,,,,,,,,,,94000.0,,,,,,,,,,600000.0,,,,12314000.0,33485000.0,6723000.0,,,,,,,,,0.0,5380000.0,,,,,,-6435000.0,-6435000.0,-6435000.0,,,33000.0,,3417000.0,,,,6542000.0,-6374000.0,,397000.0,,,584000.0,100000.0,,,,,,,,,85000.0,1000.0,0.0,,,211000.0,,,,,,,,,,,,,,,,,5000000.0,,0.0,,1691000.0,,,,,,,,,,,,,,,,,,,3814000.0,379000.0,,0.0,,,,,,,3836000.0,3836000.0,,,,,,2300000.0,,100000.0,,,100000.0,377000.0,,,-182651000.0,168000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,21171000.0,,,,,,,,,,,,0.0,,,,3538490.0,53077348.0,3538490.0,,,,,,,
2020-09-30,2020-11-12,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,232000.0,57000.0,,,,,2619000.0,137000.0,0.0,3471000.0,,208616000.0,,615000.0,,,,615000.0,,,,,32833000.0,31972000.0,,,,,,,,,,,,,,,,,,,,,,,30079000.0,,,,1.13,7535815.0,7535815.0,,0.01,100000000.0,57074478.0,57074478.0,571000.0,-5494000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,57000.0,,,,-1.48,-0.1,-1.48,,,,,,,,,,,,581000.0,3900000.0,,,,,,,,,,,,,,,,2299000.0,0.0,0.0,,,,,,,,,,,,,,,,,,93000.0,,,,,,,,,,500000.0,,,,11791000.0,32833000.0,7558000.0,,,,,,,,,0.0,4127000.0,,,,,,-5494000.0,-5494000.0,-5494000.0,,,9000.0,,4707000.0,,,,5410000.0,-5410000.0,,406000.0,,,490000.0,100000.0,,,,,,,,,81000.0,1000.0,0.0,,,106000.0,,,,,,,,,,,,,,,,0.01,5000000.0,0.0,0.0,0.0,1836000.0,,,,,,,,,,,,,,,,,,,3841000.0,370000.0,,0.0,,,,,,,3111000.0,3111000.0,,,,,,2400000.0,,100000.0,,,100000.0,379000.0,,,-188145000.0,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,21042000.0,,,,,,10000.0,4737000.0,,,,,0.0,,,,3719186.0,55787793.0,3719186.0,,,,,,,
2020-12-31,2021-03-26,10-K,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,670000.0,,-56000.0,263000.0,,,9703000.0,796000.0,0.0,3443000.0,-8000.0,218089000.0,,3629000.0,,47000.0,,3645000.0,,281000.0,28099000.0,,131255000.0,129611000.0,,0.0,8000.0,127710000.0,,,,,127702000.0,,0.0,,,,,,,,29371000.0,,,127600000.0,45897000.0,21051000.0,,,16.0,,498500.0,,0.01,200000000.0,4231135.0,4231135.0,42000.0,-110723000.0,301000.0,,,,,,,,,,,,,,,,,118000.0,,29191000.0,0.0,118000.0,22622000.0,,494000.0,,1571000.0,2037000.0,,29073000.0,,239000.0,,,,-31.13,-31.13,-31.13,0.0,0.21,0.158,,,,-0.129,-0.009,0.002,0.013,-0.004,1963000.0,9600000.0,,,-44000.0,,,,,,,,,,0.0,,,13265000.0,0.0,0.0,,,,,,,,-426000.0,,-99000.0,5012000.0,0.0,,,,159000.0,,508000.0,,,,267000.0,,,6000000.0,,,500000.0,,,,11218000.0,131255000.0,10674000.0,,,,,,,,,,0.0,,,101311000.0,-50481000.0,-29779000.0,-110715000.0,-110715000.0,-110715000.0,,,173000.0,,0.0,,,1.0,111430000.0,-110380000.0,300000.0,,455000.0,,478000.0,300000.0,,,,,,,,104100000.0,523000.0,1000.0,-8000.0,,,43000.0,-35000.0,,,3000.0,,,,,,81807000.0,,81807000.0,42000.0,,,0.01,5000000.0,0.0,0.0,0.0,1972000.0,,0.0,90997000.0,,0.0,,2000000.0,1726000.0,,,,2000000.0,0.0,,0.0,0.0,,,3752000.0,309000.0,,0.0,,,,10293000.0,,65990000.0,,28304000.0,69861000.0,,,,,2400000.0,,0.0,,0.5,300000.0,0.0,,,-278887000.0,1050000.0,,,,,,,,,,3645000.0,,,,4571288.0,,,,,,,1033256.0,,,,,,,,,,,,81742000.0,120037000.0,,,95361000.0,,,26000.0,,29000.0,,,0.0,-8000.0,0.0,0.0,17200000.0,3557065.0,3557065.0,3557065.0,16000.0,0.0,0.0,0.002,300000.0,0.0,6000000.0
2021-03-31,2021-05-07,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,3384000.0,,-232000.0,0.0,,,12764000.0,252000.0,,1765000.0,-21000.0,242304000.0,,3175000.0,,,,3175000.0,,,27251218.0,,122832000.0,121534000.0,142000.0,,,,,,,,,,,,,,,,,,,,,117100000.0,46489000.0,592000.0,,,15.94,,441545.0,,0.01,200000000.0,7231370.0,7231370.0,72000.0,-18473000.0,288000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,33000.0,,,,,-2.91,,,,,,,,,,,,,2721000.0,48400000.0,,,,,,,,,,,,,,,,6160000.0,0.0,0.0,,,,,,,,2715000.0,,,3160000.0,,,,,3622000.0,,0.0,,,,0.0,,,,,,400000.0,,,,16834000.0,122832000.0,16436000.0,,,,,,,,,,,,,1259000.0,10872000.0,-11539000.0,-18460000.0,-18460000.0,,,,55000.0,,,,,1.0,19966000.0,-18515000.0,,,355000.0,1600000.0,1600000.0,100000.0,,,,,,,,,330000.0,1000.0,-13000.0,,,33000.0,5000.0,,,,,,,0.0,,,,56652000.0,15000.0,,,0.01,5000000.0,0.0,0.0,0.0,3052000.0,,,,,1259000.0,,,,,,,67539000.0,,,0.0,,,,1913000.0,148000.0,,4000.0,,,,0.0,,,,13806000.0,,,,,,,,,,,,,,,-297347000.0,1451000.0,,,,,,,,,,3175000.0,,,,2431561.0,,,,,,,3153624.0,,,,,,,,,,,,70611000.0,105998000.0,,,,0.0,,12000.0,0.0,307000.0,,,,-13000.0,0.0,,,,6336347.0,,,,,,,,
2021-06-30,2021-08-12,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,2392000.0,,,,,,14150000.0,278000.0,,1750000.0,-12000.0,259786000.0,,3817000.0,,,,3817000.0,,,,,118202000.0,115462000.0,,,,,,,,,,,,,,,,,,,,,,109300000.0,27704000.0,,,,15.94,,441545.0,,0.01,200000000.0,8608886.0,8608886.0,86000.0,-17955000.0,288000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,25000.0,,,,-2.21,,-2.21,,,,,,,,,,,,2566000.0,36800000.0,,,,,,,,,,,-67000.0,,,,,6523000.0,0.0,0.0,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,1800000.0,,,,19290000.0,118202000.0,16830000.0,,,,,,,,,,,,,,,,-17964000.0,-17964000.0,-17964000.0,,,34000.0,,,,,,19088000.0,-17998000.0,,,412000.0,1200000.0,1567000.0,100000.0,,,,,,,,,215000.0,97000.0,9000.0,,,1167000.0,,,,,,,,,,,,,,,,0.01,5000000.0,0.0,0.0,0.0,4110000.0,,,,,,,,,,,,,,75000.0,,,,,2048000.0,298000.0,,,,,,,,,,12565000.0,,,,,,,,,,,,,,,-315311000.0,1090000.0,,,,,,,,,,,,,,2291207.0,,,,,,,2703614.0,,,,,,,,,,,,81597000.0,98912000.0,,,,0.0,,,,,,,,9000.0,,,,8106765.0,,8106765.0,,,,,,,
2021-09-30,2021-11-05,10-Q,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,3731000.0,,,,,,10320000.0,1451000.0,,1768000.0,-3000.0,372291000.0,,3982000.0,6149000.0,,,3982000.0,,,,,221205000.0,217940000.0,,,,,,,,,,,,,,,,,,,,,,213800000.0,138875000.0,,,,15.94,,441545.0,,0.01,200000000.0,19376634.0,19376634.0,194000.0,-14034000.0,288000.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30000.0,,,,-1.25,,-1.25,,,,,,,,,,,,2349000.0,42800000.0,,,,,,,,,,,,,,,,6221000.0,0.0,0.0,,,,,,,,,,,,,,,,,,0.0,,,,,,,,,,1600000.0,,,,16614000.0,221205000.0,14339000.0,,,,,,,,,,,,,,,,-14043000.0,-14043000.0,-14043000.0,,,91000.0,,,,,,14342000.0,-14134000.0,,,430000.0,1100000.0,1461000.0,100000.0,,,,,,,,,200000.0,1457000.0,9000.0,,,2275000.0,,,,,,,,,,,,,,,,,5000000.0,,,,3649000.0,,,,,,,,,,,,,,,,,,,2115000.0,347000.0,,,,,,,,,,8121000.0,,,,,,,,,,,,,,,-329354000.0,208000.0,,,,,,,,,,,,,,2969138.0,,,,,,,3367418.0,,,,,,,,,,,,74937000.0,204591000.0,,,,0.0,,,,24000.0,,,479000.0,9400.0,,,,11183578.0,,11183578.0,,,,,,,
2021-12-31,2022-03-11,10-K,"Viridian Therapeutics, Inc./DE",VRDN,CIK0001590750,USD,,,2329000.0,,-965000.0,0.0,,,11018000.0,140000.0,,1776000.0,-157000.0,412101000.0,,14442000.0,,,,14465000.0,,87000.0,23010000.0,,203709000.0,200163000.0,100000.0,6000.0,163000.0,197022000.0,,,,,196865000.0,,4000.0,,,,,,,,0.0,,,197000000.0,42299000.0,-3598000.0,,,15.91,,420629.0,,0.01,200000000.0,23924004.0,23924004.0,239000.0,-79562000.0,,,,,,,,,,,,,,,,,,439000.0,,53869000.0,0.0,439000.0,40992000.0,,1686000.0,,3123000.0,3055000.0,,53430000.0,,120000.0,,,,-6.66,,-6.66,0.0,0.21,-0.285,,,,0.0,0.0,,0.083,-0.015,3652000.0,45100000.0,,,,,,,,,,,-100000.0,,-77000.0,,,25805000.0,0.0,0.0,,,,,,,,1655000.0,,,1380000.0,636000.0,,,,1496000.0,,3000.0,,,,0.0,,,7500000.0,,,1900000.0,,,,15993000.0,203709000.0,13636000.0,,,,,,,,,,,,,125275000.0,-74292000.0,-54581000.0,-79413000.0,-79413000.0,-79413000.0,,,318000.0,,,,,1.0,82691000.0,-79728000.0,,,520000.0,1200000.0,1680000.0,500000.0,,,,,,,,,210000.0,1491000.0,-149000.0,,,1208000.0,0.0,,,0.0,,,,,,188431000.0,,,338000.0,,,,5000000.0,,,,2747000.0,,114242000.0,,,1285000.0,,46860000.0,0.0,,,,,67538000.0,100000.0,79000.0,1027000.0,,,2151000.0,375000.0,,,,,,0.0,,0.0,,56886000.0,0.0,,,,,,,,,,,,,,-358300000.0,2963000.0,,,,,,,,,,14465000.0,,,,2155945.0,,,,,,,3683839.0,,,,,,,,,,,,154666000.0,187716000.0,,,,0.0,,39000.0,,1027000.0,,,,-100000.0,0.0,0.0,24400000.0,11918712.0,,11918712.0,23000.0,4000.0,4000.0,-0.023,,39000.0,7500000.0
